Attenuated cerebrospinal fluid leukocyte count and sepsis in adults with pneumococcal meningitis: A prospective cohort study

BMC Infectious Diseases

Volumn 6, Issue , 2006, Pages

  Weisfelt, Martijn ^a   van de Beek, Diederik ^a   Spanjaard, Lodewijk ^a   Reitsma, Johannes B ^a   de Gans, Jan ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIAL MENINGITIS; BLOOD CULTURE; CARDIOPULMONARY INSUFFICIENCY; CEREBROSPINAL FLUID CULTURE; CEREBROSPINAL FLUID LEVEL; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE COURSE; ERYTHROCYTE SEDIMENTATION RATE; GLASGOW OUTCOME SCALE; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; PROTEIN CEREBROSPINAL FLUID LEVEL; RISK ASSESSMENT; RISK FACTOR; SEPSIS; THROMBOCYTE COUNT;

ADULT; CEREBROSPINAL FLUID; COHORT STUDIES; HUMANS; LEUKOCYTE COUNT; MENINGITIS, BACTERIAL; MENINGITIS, PNEUMOCOCCAL; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; SEPSIS;

EID: 33750418628     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-6-149     Document Type: Article

References (12)

1. van de Beek D, de Gans J, Tunkel AR, Wijdicks EF: Community-acquired bacterial meningitis in adults. N Engl J Med 2006, 354:44-53.
2. Weisfelt M, de Gans J, van der Poll T, van de Beek D: Pneumococcal meningitis in adults: new approaches to management and prevention. Lancet Neurol 2006, 5:332-342.
3. van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M: Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004, 351:1849-1859.
4. Weisfelt M, van de Beek D, Spanjaard L, Reitsma JB, de Gans J: Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series. Lancet Neurol 2006, 5:123-129.
5. Kastenbauer S, Pfister HW: Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases 7. Brain 2003, 126:1015-1025.
6. McMillan DA, Lin CY, Aronin SI, Quagliarello VJ: Community-acquired bacterial meningitis in adults: categorization of causes and timing of death I. Clin Infect Dis 2001, 33:969-975.
7. Ostergaard C, O'reilly T, Brandt C, Frimodt-Moller N, Lundgren JD: The Influence of the blood bacterial load on the meningeal inflammatory response in Streptococcus pneumoniae meningitis. BMC Infect Dis 2006, 6:78.
8. Jennet B, Teasdale G: Management of head injuries. Philadelphia: F A Davies 1998.
9. Brandt CT, Lundgren JD, Frimodt-Moller N, Christensen T, Benfield T, Espersen F, Hougaard DM, Ostergaard C: Blocking of leukocyte accumulation in the cerebrospinal fluid augments bacteremia and increases lethality in experimental pneumococcal meningitis. J Neuroimmunol 2005, 166:126-131.
10. Tauber MG, Kennedy SL, Tureen JH, Lowenstein DH: Experimental pneumococcal meningitis causes central nervous system pathology without inducing the 72-kd heat shock protein 4. Am J Pathol 1992, 141:53-60.
11. de Gans J, van de Beek D: Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002, 347:1549-1556.
12. van de Beek D, de Gans J: Dexamethasone and pneumococcal meningitis. Ann Intern Med 2004, 141:327.